MoneyWorks4Me

Everest Organics informs about press release

12 Oct 2021 Evaluate
Everest Organics has informed that it enclosed the Press Release for successful development of 'Molnupiravir' API, an additional COVID 19 treatment drug for patients with mild and moderate symptoms. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..